Logo image of LOPE

GRAND CANYON EDUCATION INC (LOPE) Stock Fundamental Analysis

USA - NASDAQ:LOPE - US38526M1062 - Common Stock

215.99 USD
-1.25 (-0.58%)
Last: 10/6/2025, 4:12:42 PM
215.99 USD
0 (0%)
After Hours: 10/6/2025, 4:12:42 PM
Fundamental Rating

7

LOPE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 75 industry peers in the Diversified Consumer Services industry. LOPE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LOPE has a correct valuation and a medium growth rate. With these ratings, LOPE could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

LOPE had positive earnings in the past year.
LOPE had a positive operating cash flow in the past year.
Each year in the past 5 years LOPE has been profitable.
In the past 5 years LOPE always reported a positive cash flow from operatings.
LOPE Yearly Net Income VS EBIT VS OCF VS FCFLOPE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

LOPE has a better Return On Assets (23.16%) than 97.33% of its industry peers.
LOPE has a Return On Equity of 30.40%. This is amongst the best in the industry. LOPE outperforms 90.67% of its industry peers.
LOPE has a Return On Invested Capital of 25.17%. This is amongst the best in the industry. LOPE outperforms 97.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LOPE is significantly above the industry average of 9.60%.
The 3 year average ROIC (24.24%) for LOPE is below the current ROIC(25.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 23.16%
ROE 30.4%
ROIC 25.17%
ROA(3y)22.14%
ROA(5y)20.33%
ROE(3y)28.79%
ROE(5y)25.52%
ROIC(3y)24.24%
ROIC(5y)20.99%
LOPE Yearly ROA, ROE, ROICLOPE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 22.15%, LOPE belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
In the last couple of years the Profit Margin of LOPE has declined.
LOPE's Operating Margin of 27.15% is amongst the best of the industry. LOPE outperforms 96.00% of its industry peers.
In the last couple of years the Operating Margin of LOPE has declined.
LOPE has a Gross Margin (52.97%) which is comparable to the rest of the industry.
LOPE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 27.15%
PM (TTM) 22.15%
GM 52.97%
OM growth 3Y-5.17%
OM growth 5Y-4.93%
PM growth 3Y-8.97%
PM growth 5Y-8.03%
GM growth 3Y-2.85%
GM growth 5YN/A
LOPE Yearly Profit, Operating, Gross MarginsLOPE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

10

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LOPE is creating value.
The number of shares outstanding for LOPE has been reduced compared to 1 year ago.
Compared to 5 years ago, LOPE has less shares outstanding
There is no outstanding debt for LOPE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LOPE Yearly Shares OutstandingLOPE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LOPE Yearly Total Debt VS Total AssetsLOPE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 20.95 indicates that LOPE is not in any danger for bankruptcy at the moment.
LOPE has a better Altman-Z score (20.95) than 97.33% of its industry peers.
There is no outstanding debt for LOPE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 20.95
ROIC/WACC2.87
WACC8.77%
LOPE Yearly LT Debt VS Equity VS FCFLOPE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 3.55 indicates that LOPE has no problem at all paying its short term obligations.
LOPE's Current ratio of 3.55 is amongst the best of the industry. LOPE outperforms 89.33% of its industry peers.
A Quick Ratio of 3.55 indicates that LOPE has no problem at all paying its short term obligations.
LOPE's Quick ratio of 3.55 is amongst the best of the industry. LOPE outperforms 89.33% of its industry peers.
Industry RankSector Rank
Current Ratio 3.55
Quick Ratio 3.55
LOPE Yearly Current Assets VS Current LiabilitesLOPE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.50% over the past year.
LOPE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.60% yearly.
Looking at the last year, LOPE shows a small growth in Revenue. The Revenue has grown by 6.52% in the last year.
Measured over the past years, LOPE shows a small growth in Revenue. The Revenue has been growing by 5.82% on average per year.
EPS 1Y (TTM)11.5%
EPS 3Y9.93%
EPS 5Y7.6%
EPS Q2Q%20.47%
Revenue 1Y (TTM)6.52%
Revenue growth 3Y4.84%
Revenue growth 5Y5.82%
Sales Q2Q%8.81%

3.2 Future

The Earnings Per Share is expected to grow by 12.56% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.90% on average over the next years.
EPS Next Y15.05%
EPS Next 2Y12.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.23%
Revenue Next 2Y6.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LOPE Yearly Revenue VS EstimatesLOPE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
LOPE Yearly EPS VS EstimatesLOPE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 25.32, the valuation of LOPE can be described as expensive.
Based on the Price/Earnings ratio, LOPE is valued a bit cheaper than the industry average as 61.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.86. LOPE is around the same levels.
The Price/Forward Earnings ratio is 21.18, which indicates a rather expensive current valuation of LOPE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LOPE indicates a somewhat cheap valuation: LOPE is cheaper than 62.67% of the companies listed in the same industry.
LOPE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.32
Fwd PE 21.18
LOPE Price Earnings VS Forward Price EarningsLOPE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LOPE's Enterprise Value to EBITDA ratio is in line with the industry average.
66.67% of the companies in the same industry are more expensive than LOPE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.25
EV/EBITDA 16.9
LOPE Per share dataLOPE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LOPE has an outstanding profitability rating, which may justify a higher PE ratio.
LOPE's earnings are expected to grow with 12.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.68
PEG (5Y)3.33
EPS Next 2Y12.56%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LOPE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GRAND CANYON EDUCATION INC

NASDAQ:LOPE (10/6/2025, 4:12:42 PM)

After market: 215.99 0 (0%)

215.99

-1.25 (-0.58%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners100.59%
Inst Owner Change0.02%
Ins Owners2.11%
Ins Owner Change0.22%
Market Cap6.07B
Analysts86.67
Price Target231.88 (7.36%)
Short Float %1.29%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.6%
Min EPS beat(2)0.25%
Max EPS beat(2)8.96%
EPS beat(4)2
Avg EPS beat(4)1.6%
Min EPS beat(4)-1.52%
Max EPS beat(4)8.96%
EPS beat(8)5
Avg EPS beat(8)4.58%
EPS beat(12)8
Avg EPS beat(12)5.45%
EPS beat(16)8
Avg EPS beat(16)3.55%
Revenue beat(2)1
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)0.79%
Revenue beat(4)1
Avg Revenue beat(4)-0.98%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)0.79%
Revenue beat(8)1
Avg Revenue beat(8)-0.87%
Revenue beat(12)1
Avg Revenue beat(12)-1.01%
Revenue beat(16)1
Avg Revenue beat(16)-1.42%
PT rev (1m)6.56%
PT rev (3m)4.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.74%
EPS NY rev (1m)1.19%
EPS NY rev (3m)3.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 25.32
Fwd PE 21.18
P/S 5.68
P/FCF 23.25
P/OCF 20.35
P/B 7.8
P/tB 13.15
EV/EBITDA 16.9
EPS(TTM)8.53
EY3.95%
EPS(NY)10.2
Fwd EY4.72%
FCF(TTM)9.29
FCFY4.3%
OCF(TTM)10.61
OCFY4.91%
SpS38.01
BVpS27.7
TBVpS16.43
PEG (NY)1.68
PEG (5Y)3.33
Profitability
Industry RankSector Rank
ROA 23.16%
ROE 30.4%
ROCE 32.14%
ROIC 25.17%
ROICexc 42.98%
ROICexgc 107.28%
OM 27.15%
PM (TTM) 22.15%
GM 52.97%
FCFM 24.44%
ROA(3y)22.14%
ROA(5y)20.33%
ROE(3y)28.79%
ROE(5y)25.52%
ROIC(3y)24.24%
ROIC(5y)20.99%
ROICexc(3y)34.71%
ROICexc(5y)32.22%
ROICexgc(3y)81.65%
ROICexgc(5y)77.73%
ROCE(3y)30.95%
ROCE(5y)26.8%
ROICexcg growth 3Y-12.63%
ROICexcg growth 5Y33.74%
ROICexc growth 3Y-4.05%
ROICexc growth 5Y20.74%
OM growth 3Y-5.17%
OM growth 5Y-4.93%
PM growth 3Y-8.97%
PM growth 5Y-8.03%
GM growth 3Y-2.85%
GM growth 5YN/A
F-Score8
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 97.16%
Cap/Sales 3.48%
Interest Coverage 250
Cash Conversion 90.84%
Profit Quality 110.32%
Current Ratio 3.55
Quick Ratio 3.55
Altman-Z 20.95
F-Score8
WACC8.77%
ROIC/WACC2.87
Cap/Depr(3y)119.8%
Cap/Depr(5y)287.03%
Cap/Sales(3y)4.09%
Cap/Sales(5y)9.84%
Profit Quality(3y)102.83%
Profit Quality(5y)84.76%
High Growth Momentum
Growth
EPS 1Y (TTM)11.5%
EPS 3Y9.93%
EPS 5Y7.6%
EPS Q2Q%20.47%
EPS Next Y15.05%
EPS Next 2Y12.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.52%
Revenue growth 3Y4.84%
Revenue growth 5Y5.82%
Sales Q2Q%8.81%
Revenue Next Year7.23%
Revenue Next 2Y6.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.32%
EBIT growth 3Y-0.58%
EBIT growth 5Y0.6%
EBIT Next Year27.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.92%
FCF growth 3Y39.11%
FCF growth 5Y17.26%
OCF growth 1Y28.56%
OCF growth 3Y-2.53%
OCF growth 5Y-1.09%